Chemistry:Isotocyanozene
From HandWiki
Isotocyanozene (5-cyano-isotodesnitazene) is a benzimidazole opioid analogue of isotonitazene which has been sold as a designer drug. It was first prospectively observed in a toxicological sample in Scotland, United Kingdom in 2025, and was presumed to have opioid effects.[1] It has been identified by the drug checking service CanTEST, Australia in September 2025 as an expected 'opioid' sample, and then later as an expected 'benzodiazepine' sample.[2][3] Its in vitro biological activity is close to that of fentanyl.[4]
See also
References
- ↑ "Isotocyanozene: detection of the 5-cyano analog of isotonitazene in human biological samples". Clinical Toxicology (Philadelphia, Pa.) 63 (9): 691–692. July 2025. doi:10.1080/15563650.2025.2528990. PMID 40625206.
- ↑ "Community Notice 22nd of September 2025: Isotocyanozene found in 'opioid' capsule". CanTEST. Health and drug checking service, Canberra. September 2025. https://www.instagram.com/p/DO5XilJFBLr/?utm_source=ig_web_copy_link.
- ↑ "Isotocyanozene found in 'opioid' capsule" (in en). The Know. 2025-09-22. https://theknow.org.au/alerts_warnings/isotocyanozene-found-in-opioid-capsule/.
- ↑ "Identification of isotocyanozene at an Australian drug checking service". ChemRxiv 2026 (212). doi:10.26434/chemrxiv.15000033/v1. https://chemrxiv.org/doi/full/10.26434/chemrxiv.15000033/v1.
 |  |
